vs

Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and Invesco (IVZ). Click either name above to swap in a different company.

Invesco is the larger business by last-quarter revenue ($1.7B vs $1.0B, roughly 1.7× Everus Construction Group, Inc.). Everus Construction Group, Inc. runs the higher net margin — 5.5% vs -58.9%, a 64.3% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs 6.2%). Invesco produced more free cash flow last quarter ($432.2M vs $23.5M). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 7.1%).

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

ECG vs IVZ — Head-to-Head

Bigger by revenue
IVZ
IVZ
1.7× larger
IVZ
$1.7B
$1.0B
ECG
Growing faster (revenue YoY)
ECG
ECG
+26.9% gap
ECG
33.2%
6.2%
IVZ
Higher net margin
ECG
ECG
64.3% more per $
ECG
5.5%
-58.9%
IVZ
More free cash flow
IVZ
IVZ
$408.7M more FCF
IVZ
$432.2M
$23.5M
ECG
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
7.1%
IVZ

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ECG
ECG
IVZ
IVZ
Revenue
$1.0B
$1.7B
Net Profit
$55.3M
$-995.9M
Gross Margin
11.6%
Operating Margin
6.8%
-86.2%
Net Margin
5.5%
-58.9%
Revenue YoY
33.2%
6.2%
Net Profit YoY
60.4%
-575.8%
EPS (diluted)
$1.09
$-2.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECG
ECG
IVZ
IVZ
Q4 25
$1.0B
$1.7B
Q3 25
$986.8M
$1.6B
Q2 25
$921.5M
$1.5B
Q1 25
$826.6M
$1.5B
Q4 24
$759.6M
$1.6B
Q3 24
$761.0M
$1.5B
Q2 24
$703.4M
$1.5B
Q1 24
$625.7M
$1.5B
Net Profit
ECG
ECG
IVZ
IVZ
Q4 25
$55.3M
$-995.9M
Q3 25
$57.0M
$356.4M
Q2 25
$52.8M
$197.4M
Q1 25
$36.7M
$171.1M
Q4 24
$34.5M
$209.3M
Q3 24
$41.8M
$55.0M
Q2 24
$39.0M
$132.2M
Q1 24
$28.2M
$141.5M
Gross Margin
ECG
ECG
IVZ
IVZ
Q4 25
11.6%
Q3 25
12.6%
Q2 25
13.0%
Q1 25
11.2%
Q4 24
11.4%
Q3 24
11.8%
Q2 24
12.6%
Q1 24
11.9%
Operating Margin
ECG
ECG
IVZ
IVZ
Q4 25
6.8%
-86.2%
Q3 25
7.3%
16.5%
Q2 25
7.9%
14.1%
Q1 25
6.2%
18.1%
Q4 24
6.1%
19.6%
Q3 24
7.1%
6.6%
Q2 24
7.3%
13.9%
Q1 24
6.2%
14.4%
Net Margin
ECG
ECG
IVZ
IVZ
Q4 25
5.5%
-58.9%
Q3 25
5.8%
21.7%
Q2 25
5.7%
13.0%
Q1 25
4.4%
11.2%
Q4 24
4.5%
13.1%
Q3 24
5.5%
3.6%
Q2 24
5.5%
8.9%
Q1 24
4.5%
9.6%
EPS (diluted)
ECG
ECG
IVZ
IVZ
Q4 25
$1.09
$-2.61
Q3 25
$1.11
$0.66
Q2 25
$1.03
$-0.03
Q1 25
$0.72
$0.38
Q4 24
$0.68
$0.46
Q3 24
$0.82
$0.12
Q2 24
$0.76
$0.29
Q1 24
$0.55
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECG
ECG
IVZ
IVZ
Cash + ST InvestmentsLiquidity on hand
$1.0B
Total DebtLower is stronger
$281.5M
$1.8B
Stockholders' EquityBook value
$629.8M
$12.2B
Total Assets
$1.7B
$27.1B
Debt / EquityLower = less leverage
0.45×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECG
ECG
IVZ
IVZ
Q4 25
$1.0B
Q3 25
$973.1M
Q2 25
$922.7M
Q1 25
$821.7M
Q4 24
$986.5M
Q3 24
$553.0K
$1.0B
Q2 24
$878.5M
Q1 24
$895.7M
Total Debt
ECG
ECG
IVZ
IVZ
Q4 25
$281.5M
$1.8B
Q3 25
$285.1M
$1.6B
Q2 25
$288.6M
$1.9B
Q1 25
$292.1M
$964.8M
Q4 24
$295.6M
$890.6M
Q3 24
$890.3M
Q2 24
$890.1M
Q1 24
$1.3B
Stockholders' Equity
ECG
ECG
IVZ
IVZ
Q4 25
$629.8M
$12.2B
Q3 25
$573.0M
$14.0B
Q2 25
$514.4M
$13.9B
Q1 25
$460.2M
$14.7B
Q4 24
$422.6M
$14.6B
Q3 24
$453.3M
$14.8B
Q2 24
$490.0M
$14.6B
Q1 24
$464.3M
$14.6B
Total Assets
ECG
ECG
IVZ
IVZ
Q4 25
$1.7B
$27.1B
Q3 25
$1.6B
$28.4B
Q2 25
$1.5B
$28.5B
Q1 25
$1.4B
$28.1B
Q4 24
$1.3B
$27.0B
Q3 24
$1.3B
$27.5B
Q2 24
$27.2B
Q1 24
$28.1B
Debt / Equity
ECG
ECG
IVZ
IVZ
Q4 25
0.45×
0.15×
Q3 25
0.50×
0.12×
Q2 25
0.56×
0.14×
Q1 25
0.63×
0.07×
Q4 24
0.70×
0.06×
Q3 24
0.06×
Q2 24
0.06×
Q1 24
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECG
ECG
IVZ
IVZ
Operating Cash FlowLast quarter
$48.2M
$455.8M
Free Cash FlowOCF − Capex
$23.5M
$432.2M
FCF MarginFCF / Revenue
2.3%
25.5%
Capex IntensityCapex / Revenue
2.4%
1.4%
Cash ConversionOCF / Net Profit
0.87×
TTM Free Cash FlowTrailing 4 quarters
$90.0M
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECG
ECG
IVZ
IVZ
Q4 25
$48.2M
$455.8M
Q3 25
$76.2M
$606.2M
Q2 25
$25.3M
$547.9M
Q1 25
$7.1M
$-84.6M
Q4 24
$316.9M
Q3 24
$78.9M
$438.4M
Q2 24
$489.1M
Q1 24
$21.9M
$-54.4M
Free Cash Flow
ECG
ECG
IVZ
IVZ
Q4 25
$23.5M
$432.2M
Q3 25
$65.7M
$586.4M
Q2 25
$12.3M
$530.4M
Q1 25
$-11.4M
$-108.0M
Q4 24
$309.9M
Q3 24
$60.9M
$410.0M
Q2 24
$462.4M
Q1 24
$12.6M
$-75.4M
FCF Margin
ECG
ECG
IVZ
IVZ
Q4 25
2.3%
25.5%
Q3 25
6.7%
35.7%
Q2 25
1.3%
35.0%
Q1 25
-1.4%
-7.1%
Q4 24
19.5%
Q3 24
8.0%
27.1%
Q2 24
31.2%
Q1 24
2.0%
-5.1%
Capex Intensity
ECG
ECG
IVZ
IVZ
Q4 25
2.4%
1.4%
Q3 25
1.1%
1.2%
Q2 25
1.4%
1.2%
Q1 25
2.2%
1.5%
Q4 24
0.4%
Q3 24
2.4%
1.9%
Q2 24
1.8%
Q1 24
1.5%
1.4%
Cash Conversion
ECG
ECG
IVZ
IVZ
Q4 25
0.87×
Q3 25
1.34×
1.70×
Q2 25
0.48×
2.78×
Q1 25
0.19×
-0.49×
Q4 24
1.51×
Q3 24
1.89×
7.97×
Q2 24
3.70×
Q1 24
0.77×
-0.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

Related Comparisons